{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:04:04Z","timestamp":1760551444024,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000723","name":"Tenovus","doi-asserted-by":"publisher","award":["[TIG2018-14]."],"award-info":[{"award-number":["[TIG2018-14]."]}],"id":[{"id":"10.13039\/501100000723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several epidemiological and cohort studies suggest that regular low-dose aspirin use independently reduces the long-term incidence and risk of colorectal cancer deaths by approximately 20%. However, there are also risks to aspirin use, mainly gastrointestinal bleeding and haemorrhagic stroke. Making informed decisions depends on the ability to understand and weigh up benefits and risks of available options. A decision aid to support people to consider aspirin therapy alongside participation in the NHS bowel cancer screening programme may have an additional impact on colorectal cancer prevention. This study aims to develop and user-test a brief decision aid about aspirin to enable informed decision-making for colorectal screening-eligible members of the public.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We undertook a qualitative study to develop an aspirin decision aid leaflet to support bowel screening responders in deciding whether to take aspirin to reduce their risk of colorectal cancer. The iterative development process involved two focus groups with public members aged 60\u201374\u00a0years (n\u2009=\u200914) and interviews with clinicians (n\u2009=\u200910). Interviews (n\u2009=\u200911) were used to evaluate its utility for decision-making. Analysis was conducted using a framework approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, participants found the decision aid acceptable and useful to facilitate decision-making. They expressed a need for individualised risk information, more detail about the potential risks of aspirin, and preferred risk information presented in pictograms when offered different options. Implementation pathways were discussed, including the possibility of involving different clinicians in the process such as GPs and\/or community pharmacists. A range of potentially effective timepoints for sending out the decision aid were identified<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>An acceptable and usable decision aid was developed to support decisions about aspirin use to prevent colorectal cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-021-01523-9","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:02:30Z","timestamp":1621540950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening"],"prefix":"10.1186","volume":"21","author":[{"given":"Lenira","family":"Semedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate J.","family":"Lifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Brain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3113-5472","authenticated-orcid":false,"given":"Sunil","family":"Dolwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1523_CR1","unstructured":"Cancer Research UK. Bowel cancer statistics;2017. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer. Accessed 1 Aug 2017."},{"issue":"7","key":"1523_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/gutjnl-2011-300774","volume":"61","author":"JH Scholefield","year":"2011","unstructured":"Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut. 2011;61(7):1036\u201340.","journal-title":"Gut"},{"key":"1523_CR3","unstructured":"Bowel Screening Wales. Bowel screening information booklet;2019. http:\/\/www.bowelscreening.wales.nhs.uk\/sitesplus\/documents\/1121\/BSW%20Infomation%20booklet%20_ENGLISH.pdf. Accessed 9 Jan 2019."},{"key":"1523_CR4","unstructured":"UK National Screening Committee. Recommendation on bowel cancer screening in adults;2018. https:\/\/legacyscreening.phe.org.uk\/bowelcancer. Accessed 22 Jan 2020."},{"issue":"12","key":"1523_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.31128\/AJGP-07-18-4644","volume":"47","author":"JD Emery","year":"2018","unstructured":"Emery JD, Nguyen P, Minshall J, Cummings K-L, Walker J. Chemoprevention: a new concept for cancer prevention in primary care. Aust J Gen Pract. 2018;47(12):825\u20138.","journal-title":"Aust J Gen Pract"},{"issue":"2","key":"1523_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/apt.13857","volume":"45","author":"L Emilsson","year":"2017","unstructured":"Emilsson L, Holme O, Bretthauer N, et al. The comparative effectiveness of aspirin v screening for colorectal cancer prevention. Aliment Pharmacol Ther. 2017;45(2):193\u2013204.","journal-title":"Aliment Pharmacol Ther"},{"key":"1523_CR7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741\u201350.","journal-title":"Lancet"},{"key":"1523_CR8","unstructured":"Cancer Council Australia Colorectal Cancer Guidelines Working Party;2018. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:Aspirin_for_prevention_of_colorectal_cancer. In: Cancer Council Australia Colorectal Cancer Guidelines Working Party. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney: Cancer Council Australia. Accessed 16 Oct 2018."},{"key":"1523_CR9","unstructured":"U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular disease and colorectal cancer: recommendation statement. American Family Physician. 2016;94(8):660A-F."},{"key":"1523_CR10","first-page":"951","volume":"9","author":"T Smith","year":"2015","unstructured":"Smith T, Hitchunson P, Schror K, et al. Aspirin in the 21st century-common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK. Ecancer. 2015;9:951.","journal-title":"Ecancer"},{"issue":"5","key":"1523_CR11","first-page":"429","volume":"2","author":"P Elwood","year":"2013","unstructured":"Elwood P, Steward W, Galante J. Bowel cancer prevention: screening and the role of aspirin. Bowel Cancer. 2013;2(5):429\u201339.","journal-title":"Bowel Cancer"},{"key":"1523_CR12","unstructured":"Coulter A, Collins A. Making shared decision making a reality: no decision about me without me;2011. London: King\u2019s Fund. http:\/\/www.kingsfund.org.uk\/sites\/files\/kf\/Making-shared-decision-making-a-reality-paper-Angela-Coulter-Alf-Collins-July-2011_0.pdf. Accessed 26 Nov 2019."},{"key":"1523_CR13","doi-asserted-by":"crossref","unstructured":"Stacey D, L\u00e9gar\u00e9 F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017, Issue 4. Art. No.: CD001431.","DOI":"10.1002\/14651858.CD001431.pub5"},{"key":"1523_CR14","doi-asserted-by":"crossref","unstructured":"Edwards AGK, Naik G, Ahmed H, et al. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev. 2013, Issue 2. Art. No.: CD001865.","DOI":"10.1002\/14651858.CD001865.pub3"},{"key":"1523_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pec.2010.04.034","volume":"82","author":"G Elwyn","year":"2011","unstructured":"Elwyn G, Kreuwel I, Durand M-A, et al. How to develop web-based decision support interventions for patients: a process map. Patient Educ Couns. 2011;82:260\u20135.","journal-title":"Patient Educ Couns"},{"key":"1523_CR16","unstructured":"Plain English Campaign. http:\/\/www.plainenglish.co.uk\/. Accessed 10 Dec 2018."},{"key":"1523_CR17","unstructured":"National Institute for Healthcare Research. UK Standards for Public Involvement in Research;2019. https:\/\/www.healthandcareresearch.gov.wales\/uk-standards-public-involvement\/. Accessed 22 Nov 2019."},{"issue":"9","key":"1523_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/jech.2009.087767","volume":"64","author":"P Elwood","year":"2009","unstructured":"Elwood P, Longley MJ. My health. Whose responsibility? J Epidemiol Commun Health. 2009;64(9):761\u20134.","journal-title":"J Epidemiol Commun Health"},{"key":"1523_CR19","unstructured":"NVivo qualitative data analysis Software (Version 12) Melbourne: QSR International Pty Ltd, 2018."},{"key":"1523_CR20","first-page":"173","volume-title":"Analysing qualitative data \u201cAnalyzing qualitative data\u201d","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analysing qualitative data \u201cAnalyzing qualitative data.\u201d London: Routledge; 1994. p. 173\u201394."},{"key":"1523_CR21","unstructured":"NHS Yorkshire and the Humber. Prevention and lifestyle behaviour change competence framework;2010. NHS Yorkshire and the Humber. Available from: http:\/\/www.makingeverycontactcount.co.uk . Accessed 12 Aug 2019."},{"issue":"7565","key":"1523_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","volume":"333","author":"G Elwyn","year":"2006","unstructured":"Elwyn G, O\u2019Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international. Delphi consensus process International Patient Decision Aids Standards (IPDAS) Collaboration. BMJ. 2006;333(7565):417.","journal-title":"BMJ"},{"issue":"12","key":"1523_CR23","doi-asserted-by":"publisher","first-page":"e0189148","DOI":"10.1371\/journal.pone.0189148","volume":"12","author":"M Reder","year":"2017","unstructured":"Reder M, Kolip P. Does a decision aid improve informed choice in mammography screening? Results from a randomised controlled trial. PLoS ONE. 2017;12(12):e0189148.","journal-title":"PLoS ONE"},{"issue":"6","key":"1523_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.amepre.2011.02.019","volume":"40","author":"D Miller","year":"2011","unstructured":"Miller D, Spangler J, Case D, Goff D, Singh S, Pignone M. Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med. 2011;40(6):608\u201315.","journal-title":"Am J Prev Med"},{"issue":"2","key":"1523_CR25","first-page":"S6.25","volume":"13","author":"P Abhyankar","year":"2013","unstructured":"Abhyankar P, Volk RJ, Blumenthal-Barby J, et al. Balancing the presentation of information and options in patient decision aids: an updated review. BMC Med Inform Decis Mak. 2013;13(2):S6.25.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"7","key":"1523_CR26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.amjmed.2018.12.037","volume":"132","author":"B Fiedler","year":"2019","unstructured":"Fiedler B, Fiedler L, DeDonno M, et al. Underutilization of aspirin in patients with advanced colorectal polyps. Am J Med. 2019;132(7):884\u20135.","journal-title":"Am J Med"},{"issue":"17","key":"1523_CR27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1001\/jama.2019.4755","volume":"321","author":"H Brenner","year":"2019","unstructured":"Brenner H, Calderazzo S, Seufferlein T, et al. Effect of a single aspirin dose prior to fecal immunochemical testing on test sensitivity for detecting advanced colorectal neoplasms: a randomized clinical trial. JAMA. 2019;321(17):1686\u201392.","journal-title":"JAMA"},{"issue":"6","key":"1523_CR28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1053\/j.gastro.2019.01.040","volume":"156","author":"KR Randel","year":"2019","unstructured":"Randel KR, Botteri E, Romstad KMK, et al. Effects of oral anticoagulants and aspirin on performance of fecal immunochemical tests in colorectal cancer screening. Gastroenterology. 2019;156(6):1642-1649.e1.","journal-title":"Gastroenterology"},{"issue":"1","key":"1523_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/2050640617707094","volume":"6","author":"L Bujanda","year":"2018","unstructured":"Bujanda L, Sarasqueta C, Vega P, et al. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia. U Eur Gastroenterol J. 2018;6(1):123\u201330.","journal-title":"U Eur Gastroenterol J"},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/gutjnl-2018-316344","volume":"68","author":"SAV Nieuwenburg","year":"2019","unstructured":"Nieuwenburg SAV, Vuik FER, Kruip MJHA, Kuipers EJ, Spaander MCW. Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis. Gut. 2019;68:866\u201372.","journal-title":"Gut"},{"issue":"10145","key":"1523_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","volume":"392","author":"PM Rothwell","year":"2018","unstructured":"Rothwell PM, Cook NR, Gaziano JM, Price JF, Belch JFF, Roncaglioni MC, et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet. 2018;392(10145):387\u201399.","journal-title":"Lancet"},{"issue":"1","key":"1523_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3122\/jabfm.2014.01.130040","volume":"27","author":"BJ Wells","year":"2014","unstructured":"Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S. Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study. J Am Board Fam Med. 2014;27(1):42\u201355.","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"1523_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1200\/JCO.2008.17.4797","volume":"27","author":"AN Freedman","year":"2009","unstructured":"Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27(5):686\u201393.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1523_CR34","doi-asserted-by":"publisher","first-page":"e007825","DOI":"10.1136\/bmjopen-2015-007825","volume":"5","author":"J Hippisley-Cox","year":"2015","unstructured":"Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study. BMJ Open. 2015;5(3):e007825.","journal-title":"BMJ Open"},{"issue":"1","key":"1523_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12911-017-0407-7","volume":"17","author":"JG Walker","year":"2017","unstructured":"Walker JG, Bickerstaffe A, Hewabandu N, et al. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care. BMC Med Inform Decis Mak. 2017;17(1):13.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"689","key":"1523_CR36","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.3399\/bjgp19X706613","volume":"69","author":"P Nguyen","year":"2019","unstructured":"Nguyen P, McIntosh J, Bickerstaffe A, Maddumarachchi S, Cummings K-L, Emery JD. Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care. Br J Gen Pract. 2019;69(689):e843\u20139.","journal-title":"Br J Gen Pract"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-021-01523-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:04:07Z","timestamp":1621541047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-021-01523-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1186\/s12911-021-01523-9","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present research received approval from Cardiff University School of Medicine Institutional Review Board [reference 18\/23]. Informed consent was obtained in written format from the study participants prior to study commencement. Participants provided their consent to take part in the study as well to use the words mentioned in the focus groups\/interviews anonymously. All personal identifiers were removed so that participants cannot be identified in the presentation of research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}